Investigacion |
| Alguna Pregunta? |
|
|
Abstract clinical tests evaluation
On the 24th of November, 2004, the assessment of clinical tests of the medical device "Electromagnetic Stimulator Potency®" was issued by Santariskiu Nephrology and Urology centre at Vilnius University Hospital.
We are tendering the extract of the clinical tests evaluation:
/...Analysing the report of this test, it is stated, that a double blind, controlled by the placebo, test, has been performed with 47 patients involved. The results have been assessed according to the unique SVF scale.
Having evaluated the results of the tests, it is stated that the device has positive effect on sexual function of 61,1 per cent of patients and the improvement in the placebo group comprises 27,3 per cent.
On the ground of this test and the quantitative assessment according to SVF scale, we conclude that the electromagnetic stimulator has reliable positive effect. Besides, the electromagnetic field it is evaluated as weak, but having no side effect.
We are stating, that the double blind clinical test, controlled by the placebo is sufficient to form the above stated conclusions as well as to recommend the electromagnetic stimulator for medical treatment.
Prof. B.Dainys
Dr. H.Ramonas
Vilnius University Hospital
Dept. Nephrology and urology centre
PEMF for erectile dysfunction: Pelka RB, Jaenicke C, Gruenwald J. Universitat der Bundeswehr, Neubiberg/Munich, Germany.
This double blind, placebo-controlled study assessed the efficacy of 3 weeks of PEMF for erectile dysfunction (ED).
Twenty volunteers who suffered from ED or orgasmic disturbances were randomly assigned to either active treatment or placebo (n = 10 each).
Efficacy was assessed in terms of intensity and duration of erection, general wellbeing, sexual activity, and warm sensation in the genital area.
In the active-treatment group, all efficacy endpoints were significantly improved at study end (P < or = .01), with 80% reporting increases in intensity and duration of erection, frequency of genital warmth, and general well-being.
The remaining 20%, who experienced minor improvements, were found to have an influenza-like infection after the study that may have influenced their results.
Only 30% of the placebo group noted some improvement in their sexual activity;
70% had no change.
No side effects were reported.
PMID: 12008861 PubMed
Adv Ther. 2002 Jan-Feb;19(1):53-60.
|
|
Inicio